(lp0
S"Horizon Pharma plc Announces &quot;UCD in Common&quot; for the Urea Cycle Disorder (UCD ... GlobeNewswire  - Mar 16, 2017 DUBLIN, Ireland, March 16, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;...Putnam Investments LLC Has $2243000 Position in Horizon Pharma PLC  - The Cerbat Gem"
p1
aS"Horizon Pharma plc Launches RAREis Campaign Elevating Faces of the Rare ... GlobeNewswire  - Feb 28, 2017 DUBLIN, Ireland, Feb. 28, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p2
aS"Horizon Pharma plc to Host Fourth-Quarter 2016 Conference Call and Webcast on ... GlobeNewswire  - Jan 27, 2017 DUBLIN, Ireland, Jan. 27, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p3
aS"Horizon Pharma plc to Participate in Cowen and Company 37th Annual Health Care ... GlobeNewswire  - Feb 14, 2017 DUBLIN, Ireland, Feb. 14, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p4
aS"Horizon Pharma plc Announces Urea Cycle Disorders Medical Foods and ... GlobeNewswire  - Mar 2, 2017 DUBLIN, Ireland, March 02, 2017  -- Horizon Pharma plc , a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible&nbsp;..."
p5
aS'Global Genes and Horizon Pharma plc Partner to Offer Nephropathic Cystinosis ... PR Newswire  - Jan 17, 2017 17, 2017 /PRNewswire-USNewswire/ -- Global Genes and Horizon Pharma plc  announced the Horizon Nephropathic Cystinosis Scholarship , an exclusive opportunity for people living with nephropathic cystinosis to further their&nbsp;...Rare Disease College Report: Nephropathic Cystinosis Scholarships Available - Rare Disease Report'
p6
aS'Horizon Pharma plc  Moves Lower on Volume Spike for March 07 Equities.com - Mar 7, 2017 Horizon Pharma plc  traded on unusually high volume on Mar. 07, as the stock lost 3.42% to close at $14.97. On the day, Horizon Pharma plc saw 5.56 million shares trade hands on 33,005 trades. Considering that the stock averages only a daily&nbsp;...Horizon Pharma plc  Quarterly EPS At $0.84 - Stock ObserverHorizon Pharma PLC  PT Lowered to $22.00 - Chaffey Breeze'
p7
aS'Stock Price of Horizon Pharma plc  Decreases -1.75% Highland Mirror - 20 hours ago Horizon Pharma plc s trend and data analysis indicates that the stock price has dropped -11.11% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -16.55% .PPL Corp  &amp; Horizon Pharma PLC  Stocks Buzz - Daily News JournalHorizon Pharma plc  Quarterly Deferred Revenue At $3.321 Millions - Enterprise Leader'
p8
aS'Horizon Pharma plc  Moves Higher on Volume Spike for February 24 Equities.com - Feb 24, 2017 Horizon Pharma plc  traded on unusually high volume on Feb. 24, as the stock gained 1.75% to close at $17.45. On the day, Horizon Pharma plc saw 3.91 million shares trade hands on 22,002 trades. Considering that the stock averages only a daily&nbsp;...Earnings Guidance on Horizon Pharma PLC - Energy IndexHorizon Pharma plc : Analysts bet a 144.9 percent change in price - Post Analyst'
p9
aS'Stock Returns: Horizon Pharma plc  is Beating Endo International ... CML News - 10 hours ago This is a snapshot to compare the stock returns for Endo International plc  versus Horizon Pharma plc  .'
p10
a.